Background: The rise within the variety of most cancers circumstances and the evolution of most cancers care administration have turn out to be a big downside for the French well being care system, thereby making affected person empowerment as a protracted sought-after purpose in continual pathologies. The implementation of an activation measure through the Affected person Activation Measure-13 merchandise (PAM-13) in the midst of most cancers care can probably spotlight the affected person’s wants, with nursing care adapting accordingly.

Goal: The goals of this PARACT (PARAmedical Interventions on Affected person ACTivation) multicentric research have been as follows: (1) consider the implementation of PAM-13 in oncology nursing practices in 5 complete most cancers facilities, (2) determine the obstacles and facilitators to the implementation of PAM-13, and (3) produce suggestions for the dissemination of such interventions in different complete most cancers facilities.

Strategies: This research will comply with the “Attain, Effectiveness, Adoption, Implementation, and Upkeep” framework and can consist of three phases. First, a strong preimplementation evaluation will probably be performed utilizing the Theoretical Domains Framework (TDF) linked to the “Functionality, Alternative, Motivation, and Conduct” mannequin to determine the obstacles and facilitators to implementing new nursing practices in every context. Then, utilizing the Conduct Change Wheel, we are going to personalize a technique for implementing the PAM-13, relying on the specificities of every context, to encourage acceptability by the nursing employees concerned within the mission. This evaluation will probably be carried out through a qualitative research by way of semistructured interviews.

Second, the affected person will probably be included within the research for 12 months, throughout which the affected person care pathway will probably be studied, significantly to gather all related contacts of oncology nurses and different well being professionals concerned within the pathway. The axes of nursing care may even be collected. The first purpose is to implement PAM-13. Secondary elements to be measured are the affected person’s nervousness stage, high quality of life, and well being literacy stage. The oncology nurses will probably be liable for finishing the questionnaires when the affected person is on the hospital for his/her intravenous chemotherapy/immunotherapy remedy. The questionnaires will probably be accomplished thrice in a 12 months: (1) on the time of the affected person’s enrollment, (2) at 6 months, and (3) at 12 months. Third, a postimplementation evaluation will probably be carried out by way of semistructured interviews utilizing the TDF to research the implementation issues at every website.

Outcomes: This research was supported by a grant from the French Ministry of Well being (PHRIP PARACT 2016-0405) and the Lucien Neuwirth Institute of Cancerology of Saint-Etienne, France. Knowledge assortment for this research is ongoing.

Conclusions: This research would enhance the carried out focused nursing interventions in most cancers facilities so {that a} affected person is obtainable a customized most cancers care pathway. Moreover, measuring the extent of activation and the implementation of measures meant to extend such activation may represent a big benefit in decreasing social well being inequalities.

In lots of cancers, tumour development is related to elevated tissue stiffness. But, the mechanisms associating tissue stiffness with tumorigenesis and malignant transformation are unclear. Right here we present that in gastric most cancers cells, the stiffness of the extracellular matrix reversibly regulates the DNA methylation of the promoter area of the mechanosensitive Sure-associated protein (YAP). Reciprocal interactions between YAP and the DNA methylation inhibitors GRHL2, TET2 and KMT2A may cause hypomethylation of the YAP promoter and stiffness-induced oncogenic activation of YAP.

Breast cancer
BR724	TissueArray	each	EUR 270
Description: Breast cancer, adjacent and adjacent normal tissue array, 66 cases/72 cores

Breast cancer
BR725	TissueArray	each	EUR 270
Description: Breast cancer, adjacent and adjacent normal tissue array, 68 cases/72 cores

Human Cancer Antigen 15-3 (CA 15-3) ELISA Kit
PRB-5069	Cell Biolabs	96 assays	EUR 686.4

Human Cancer Antigen 15-3 (CA 15-3) ELISA Kit
PRB-5069-5	Cell Biolabs	5 x 96 assays	EUR 2739.6

Gastrointestinal Cancer Antigen (CA 19-9), antigen grade
CA1991-N-10	Alpha Diagnostics	10 KU	EUR 634.8

Cancer Antigen 15-3 MUC 1 Antigen (Human Milk)
VAng-Cr3871-10kU	Creative Biolabs	10 kU	EUR 505.2
Description: Cancer Antigen 15-3 MUC 1 Antigen, Host/Source: Human Milk. The purity is detected by salt extraction and delipidization following high speed centrifugation. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2.

Paraffin Tissue Section - Human Breast Tumor: Lobular carcinoma
T2235086-3	Biochain	5 slides	EUR 308.4
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool.

Breast Cancer-Associated Antigen BRCAA1 (BRCAA1) Antibody
20-abx148333	Abbexa	EUR 510.00 EUR 410.40	100 ug 50 ug

Breast tumor tissue array (15 of 25)
BR20821	TissueArray	each	EUR 474
Description: Breast tumor tissue array (15 of 25), including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2) results,104 cases/208 cores

BSA (Standard Grade)
30-AB70	Fitzgerald	1 kg	EUR 1078.8
Description: Standard Grade Bovine Serum Albumin (99% pure)

Cancer Antigen 15-3 MUC 1 Antigen (Human Ascites Fluid)
VAng-Cr3872-10kU	Creative Biolabs	10 kU	EUR 1363.2
Description: Cancer Antigen 15-3 MUC 1 Antigen, Host/Source: Human Ascites Fluid.

Cancer Antigen CA 15-3 Protein (Human Fluids)
VAng-Wyb8628-inquire	Creative Biolabs	inquire	Ask for price
Description: CA 15-3 (Breast Cancer Antigen), Cancer antigen from Human Fluids, 12.240 kU/mL.

Cancer Antigen CA 15-3 Protein (Human Milk)
VAng-Wyb8631-inquire	Creative Biolabs	inquire	Ask for price
Description: CA 15-3 (Breast Cancer Antigen), Antigen Grade, Cancer antigen from Human Milk, 33.0 kIU/mL.

Paraffin Tissue Section - Human Brain Tumor: Astrocytoma Grade III
T2235035-3	Biochain	5 slides	EUR 308.4
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool.

Breast cancer with cancer adjacent breast tissue array
BC081116e	TissueArray	each	EUR 306
Description: Breast cancer with cancer adjacent breast tissue array, including invasive carcinoma of no special type, breast carcinoma with apocrine differentiation and AT tissue,pat hology grade, IHC (ER/PR/Her-2/Ki67) info, TNM/Stage (AJCC 7th edition), 107 cases/110 cores (core size 1.5mm), replacing BC081116d

Cancer Antigen 15-3 (CA15-3) (human) ELISA Kit
K4804-100	Biovision	100 assays	EUR 1000.8
Description: Sensitive, Colorimetric Assay

Breast cancer TMA
BR602	TissueArray	each	EUR 270
Description: Breast cancer TMA, 3 samples have matched cancer adjacent tissue samples, including pathology grade, TNM and clinical stage (reference AJCC 8th version), 57 cases/60 cores (Core Size 1.5mm), recent tear collections

Organic Wine Standard 3
WINE-3	Scientific Laboratory Supplies	1ML	EUR 258.78

Human Cancer PrimaCell4: Breast Tumor Cells Growth Medium
9-46027	CHI Scientific	5 x 100 ml	Ask for price

Breast cancer with matched cancer adjacent breast tissue array
BR804b	TissueArray	each	EUR 306
Description: Breast cancer with matched cancer adjacent breast tissue array, including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2 and Ki67), 40 cases/80 cores, replacing BR804a

Breast cancer with breast tissue array
BC08118a	TissueArray	each	EUR 258
Description: Breast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 100 cases/100 cores (core size 1.0mm), replacing BC08118

Breast cancer with breast tissue array
BR2085d	TissueArray	each	EUR 546
Description: Breast cancer with breast tissue array, including pathology grad, TNM and clinical stage, 188 cases/208 cores, replacing BR2085c

Breast cancer with breast tissue array
BR246d	TissueArray	each	EUR 66
Description: Breast cancer with breast tissue array, including pathology grade, TNM and clinical stage (reference AJCC 7th version), 12 cases/24 cores, replacing BR246c

Breast cancer with breast tissue array
BR482	TissueArray	each	EUR 198
Description: Breast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 24 cases/48 cores

Breast cancer with breast tissue array
BR720	TissueArray	each	EUR 270
Description: Breast cancer with breast tissue array, including pathology grade, TNM and clinical satge (reference AJCC 7th version), 72 cases/72 cores

Breast cancer with breast tissue array
T087d	TissueArray	each	EUR 66
Description: Breast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T087c

Breast cancer with breast tissue array
T088d	TissueArray	each	EUR 66
Description: Breast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T088c

Human Cancer Tissue Preparation Buffer 4: Breast Tumor Cells
9-80027	CHI Scientific	1 x 100 ml	Ask for price

Breast cancer tissue array
BR042b	TissueArray	each	EUR 78
Description: Breast cancer tissue array, including TNM and pathology grade, 4 cases/4 cores, replacing BR042a

Breast cancer tissue array
BR1006a	TissueArray	each	EUR 306
Description: Breast cancer tissue array, including pathology grade, TNM and clinical stage, 50 cases/100 cores (core size 1.0mm), replacing BR1006

Breast cancer tissue array
BR1141a	TissueArray	each	EUR 354
Description: Breast cancer tissue array, including pathology grade, TNM and clinical stage, IHC marker (ER, PR, HER2 and Ki-67), 114 cases/114 cores, replacing BR1141

Breast cancer tissue array
BR1401	TissueArray	each	EUR 414
Description: Breast cancer tissue array, including TNM and pathology grade, IHC markers ER/PR/Her-2 results, 140 cases/140 cores (core size 1.0mm)

Breast cancer tissue array
BR1503f	TissueArray	each	EUR 306
Description: Breast cancer tissue array, including TNM and pathology grade, with IHC results of Her-2\ER\PR\Ki67, 75 cases/ 150 cores, replacing BR1503e

Breast cancer tissue array
BR1505e	TissueArray	each	EUR 306
Description: Breast cancer tissue array, including pathology grade, TNM, clinical stage, and IHC(HER2/ER/PR/Ki67), 75 cases/150 cores, replacing BR1505d

Breast cancer tissue array
BR2161	TissueArray	each	EUR 546
Description: Breast cancer tissue array, including TNM and pathology grade, 216 cases/216 cores

Breast cancer tissue array
BR247a	TissueArray	each	EUR 234
Description: Breast cancer tissue array, with normal tissue, including TNM and pathology grade, IHC marker (HER2), 24 cases/48 cores replacing BR247

Breast cancer tissue array
BR488	TissueArray	each	EUR 306
Description: Breast cancer tissue array, including pathology grade, TNM, clinical stage (AJCC 7th edition), and IHC marker(ER,PR,Her-2), 48 cases/48 cores

Breast cancer tissue array
BR501	TissueArray	each	EUR 270
Description: Breast cancer tissue array, including TNM and pathology grade, 50 cases/ 50 cores (core size 1.5mm)

Breast cancer tissue array
BR8015a	TissueArray	each	EUR 306
Description: Breast cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases/80 cores, replacing BC08014

Breast cancer tissue array
BR964	TissueArray	each	EUR 222
Description: Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/96 cores

Breast cancer tissue array
T089c	TissueArray	each	EUR 48
Description: Breast cancer tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores(1.5mm), replacing T089b

Breast cancer and normal tissue array with stage and grade info
BR8012	TissueArray	each	EUR 306
Description: Breast cancer and normal tissue array with stage and grade info, 40 cases/80 cores, replaced by BR8014

Human Carbohydrate Antigen 15-3 (CA15-3) ELISA Kit
DLR-CA15-3-Hu-48T	DL Develop	48T	EUR 574.8
Description: A sandwich quantitative ELISA assay kit for detection of Human Carbohydrate Antigen 15-3 (CA15-3) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Human Carbohydrate Antigen 15-3 (CA15-3) ELISA Kit
DLR-CA15-3-Hu-96T	DL Develop	96T	EUR 745.2
Description: A sandwich quantitative ELISA assay kit for detection of Human Carbohydrate Antigen 15-3 (CA15-3) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Human Carbohydrate Antigen 15-3 (CA15-3) ELISA Kit
RDR-CA15-3-Hu-48Tests	Reddot Biotech	48 Tests	EUR 600

Human Carbohydrate Antigen 15-3 (CA15-3) ELISA Kit
RDR-CA15-3-Hu-96Tests	Reddot Biotech	96 Tests	EUR 830.4

Human Carbohydrate Antigen 15-3 (CA15-3) ELISA Kit
RD-CA15-3-Hu-48Tests	Reddot Biotech	48 Tests	EUR 573.6

Human Carbohydrate Antigen 15-3 (CA15-3) ELISA Kit
RD-CA15-3-Hu-96Tests	Reddot Biotech	96 Tests	EUR 794.4

99445-15 DCT 15 X 85MM
99445-15	CORNING	250/pk	EUR 116.4
Description: Disposable Culture Tubes; DCT's, CGW

Multiple breast cancer with breast tissue array
BR087e	TissueArray	each	EUR 48
Description: Multiple breast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing BR087d

Breast cancer with matched breast tissue array
BR251e	TissueArray	each	EUR 60
Description: Breast cancer with matched breast tissue array, including pathology grade, IHC info (ER,PR,Her-2,Ki67),TNM\Stage, 6 cases/24 cores (core size 1.5mm), replacing BR251d

Fluorescent Exosome Standard (Urine )
ESF-15	Creative Biolabs	100 µg	EUR 2067.6
Description: Fluorescent exosomes are labeled with green dye, which offer a stable fluorescent labeling.

Breast cancer tissue array with cancer adjacent breast tissue as control
BR208a	TissueArray	each	EUR 474
Description: Breast cancer tissue array with cancer adjacent breast tissue as control, including TNM, clinical stage and pathology grade, 69 cases/ 207 cores.

CA 15-3, Human Breast Adenocarcinoma
P1435-1	Biovision	each	EUR 130.8

CA 15-3, Human Breast Adenocarcinoma
P1435-5	Biovision	each	EUR 288

Inactivated CMV Grade 3 Antigen
VAng-Lsx0038-1mg	Creative Biolabs	1 mg	EUR 2503.2
Description: CMV Grade 3, natural protein.

Inactivated MuV Grade 3 Antigen
VAng-Lsx0411-inquire	Creative Biolabs	inquire	Ask for price
Description: MuV grade 3, native protein.

Inactivated Rotavirus Grade 3 Antigen
VAng-Lsx0469-inquire	Creative Biolabs	inquire	Ask for price
Description: Rotavirus Grade 3, native virus.

Inactivated RuV Grade 3 Antigen
VAng-Lsx0476-1mL	Creative Biolabs	1 mL	EUR 474
Description: RuV Grade 3, natural protein.

Cancer Antigen 242 Antigen
VAng-Cr3876-10kU	Creative Biolabs	10 kU	EUR 505.2
Description: Cancer Antigen 242 Antigen, Host/Source: Metastatic Liver. The purity is detected by gel filtration.

Cancer Antigen 50 Antigen
VAng-Cr3877-50kU	Creative Biolabs	50 kU	EUR 6642
Description: Cancer Antigen 50 Antigen, Host/Source: Human Cell Culture. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2.

ICP-MS Calibration Standard 3
CL-CAL-3	Scientific Laboratory Supplies	125ML	EUR 121.98

Proteinase K, Recombinant, Standard Grade
9250-100	Biovision	each	EUR 124.8

Proteinase K, Recombinant, Standard Grade
9250-10G	Biovision	each	EUR 4627.2

Proteinase K, Recombinant, Standard Grade
9250-1G	Biovision	each	EUR 548.4

Proteinase K, Recombinant, Standard Grade
9250-500	Biovision	each	EUR 314.4

Proteinase K, Recombinant, Standard Grade
9251-100	Biovision	each	EUR 1266

Proteinase K, Recombinant, Standard Grade
9251-25	Biovision	each	EUR 352.8

Proteinase K, Recombinant, Standard Grade
9251-5	Biovision	each	EUR 144

Breast cancer (including one case of male breast cancer) with adjacent normal breast tissue array
BC081120g	TissueArray	each	EUR 306
Description: Breast cancer (including one case of male breast cancer) with adjacent normal breast tissue array, including pathology grade, TNM and clinical stage (AJCC 7th edition) with IHC results ER/PR/Her2/Ki67,110 cases/110 cores (core size 1.0 mm), replacing BC081120f

Breast cancer with adjacent normal breast tissue array
BR1921c	TissueArray	each	EUR 546
Description: Breast cancer with adjacent normal breast tissue array, including pathology grade, TNM, clinical stage and IHC marker (ER, PR and Her-2), 189 cases/192 cores, replacing BR1921b

Breast disease spectrum (breast cancer progression) tissue array
BR2082c	TissueArray	each	EUR 546
Description: Breast disease spectrum (breast cancer progression) tissue array, including pathology grade, TNM and clinical stage, IHC marker (ER, PR, HER2 and Ki-67), 186 cases/192 cores, replacing BR2082b

Breast cancer with adjacent normal breast tissue array
BR803c	TissueArray	each	EUR 258
Description: Breast cancer with adjacent normal breast tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores, replacing BR803b

Breast cancer with adjacent normal breast tissue array
BR901a	TissueArray	each	EUR 270
Description: Breast cancer with adjacent normal breast tissue array, including pathology grade, TNM and clinical stage, 45 cases/90 cores, replacing BR901

Breast normal tissue with breast cancer tissue array
BRN801c	TissueArray	each	EUR 270
Description: Breast normal tissue with breast cancer tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores, replacing BRN801b

Polystyrene Particle Size Standard
PPS-3	Spherotech	mL	EUR 152.4
Description: Please reffer to the technical data sheet for more detail information for this item. Our dedicated team would be happy to assist you via live chat, email or phone.

Breast Cancer Metastasis Suppressor 1
PR27265	Neuromics	2 ug	EUR 229.2

Breast cancer test tissue array
T086e	TissueArray	each	EUR 66
Description: Breast cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing T086d

Breast Tumor Kinase antibody
70R-31875	Fitzgerald	100 ug	EUR 392.4
Description: Rabbit polyclonal Breast Tumor Kinase antibody

Breast Tumor Kinase antibody
70R-33385	Fitzgerald	100 ug	EUR 392.4
Description: Rabbit polyclonal Breast Tumor Kinase antibody

Breast Tissue Lysate (Tumor)
1713-01	ProSci	0.1 mg	EUR 336.3
Description: Breast tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Breast Tissue Lysate (Tumor)
1713-02	ProSci	0.1 mg	EUR 336.3
Description: Breast tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Breast Tissue Lysate (Tumor)
1714-01	ProSci	0.1 mg	EUR 336.3
Description: Breast tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Breast Tissue Lysate (Tumor)
1714-02	ProSci	0.1 mg	EUR 336.3
Description: Breast tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Breast Tissue Lysate (Tumor)
1714-03	ProSci	0.1 mg	EUR 336.3
Description: Breast tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Breast Tissue Lysate (Tumor)
1714-04	ProSci	0.1 mg	EUR 336.3
Description: Breast tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Breast Tissue Lysate (Tumor)
1714-05	ProSci	0.1 mg	EUR 336.3
Description: Breast tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Breast Tissue Lysate (Tumor)
1714-06	ProSci	0.1 mg	EUR 336.3
Description: Breast tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Breast Tissue Lysate (Tumor)
1714-07	ProSci	0.1 mg	EUR 336.3
Description: Breast tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Human Breast Tumor lysate
HTL-1323	Alpha Diagnostics	1 mg	EUR 927.6

Breast Membrane Tumor Lysate
XBL-10499	ProSci	0.1 mg	EUR 752.1
Description: Human breast tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human breast tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated breast tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated breast tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal.

ICP-MS Instrument Check Standard 3
CL-ICS-3	Scientific Laboratory Supplies	125ML	EUR 175.56

Cancer Antigen 72-4 Antigen
VAng-Cr3878-10kU	Creative Biolabs	10 kU	EUR 505.2
Description: Cancer Antigen 72-4 Antigen, Host/Source: Metastatic Liver. The purity is ~65% by SDS-PAGE. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2.

Advanced stage breast cancer and normal breast tissue array
BR1191	TissueArray	each	EUR 306
Description: Advanced stage breast cancer and normal breast tissue array, including pathology grade, TNM and clinical stage (AJCC 8.0), ER\PR\HER-2\Ki-67 marker, 119 cases/119 cores, (1.5mm)

Breast cancer tissue array with adjacent normal breast tissue
BR8011a	TissueArray	each	EUR 306
Description: Breast cancer tissue array with adjacent normal breast tissue, including TNM, clinical stage, pathology grade and DCIS, 80 cases/80 cores, replacing BR8011

Breast cancer with matched or unmatched breast tissue array
BR802c	TissueArray	each	EUR 270
Description: Breast cancer with matched or unmatched breast tissue array, including pathology grade, TNM and clinical stage, 53 cases/80 cores, replacing BR802b

Human CA15-3 Antigen Grade Protein
abx060972-250kU	Abbexa	250 kU	EUR 2380.8

Inactivated PIV-3 Grade 2 Antigen
VAng-Wyb3637-1mL	Creative Biolabs	1 mL	EUR 1363.2
Description: Parainfluenza virus type 3 (strain C243) Grade 2, natural antigen

Inactivated HSV-1 Grade 3 Antigen
VAng-Lsx0293-1mg	Creative Biolabs	1 mg	EUR 1786.8
Description: HSV Type 1 Grade III, native antigen.

Inactivated HSV-2 Grade 3 Antigen
VAng-Lsx0302-1mg	Creative Biolabs	1 mg	EUR 1786.8
Description: HSV Type 2 Grade III, native antigen.

Microplate cell grade 96well ps standard
781965	Scientific Laboratory Supplies	PK50	EUR 347.47

Prostate Specific Antigen Std Grade Antigen
VAng-Cr3891-1mg	Creative Biolabs	1 mg	EUR 604.8
Description: Prostate Specific Antigen Std Grade Antigen, Host/Source: Human Seminal Fluid. The purity is detected by salt precipitation.

CEA Antigen Grade Protein
abx060976-05mg	Abbexa	0.5 mg	EUR 1161.6

CEA Antigen Grade Protein
abx060977-1mg	Abbexa	1 mg	EUR 2030.4

Breast Cancer Anti-Estrogen Resistance 3 (BCAR3) Antibody
20-abx171475	Abbexa	EUR 1028.40 EUR 526.80	1 mg 200 ug

Breast Cancer-Associated Gene 3 Protein (BCA3) Antibody
20-abx133658	Abbexa	EUR 360.00 EUR 526.80 EUR 226.80	100 ul 200 ul 30 ul

Breast Cancer Anti-Estrogen Resistance 3 (BCAR3) Antibody
20-abx129227	Abbexa	EUR 510.00 EUR 159.60 EUR 1446.00 EUR 693.60 EUR 393.60	100 ug 10 ug 1 mg 200 ug 50 ug

Breast Cancer-Associated Gene 3 Protein (BCA3) Antibody
20-abx013807	Abbexa	EUR 376.80 EUR 117.60 EUR 477.60 EUR 594.00	100 ug 10 ug 200 ug 300 µg

Breast Cancer-Associated Gene 3 Protein (BCA3) Antibody
abx025588-400ul	Abbexa	400 ul	EUR 627.6

Breast Cancer-Associated Gene 3 Protein (BCA3) Antibody
abx025588-80l	Abbexa	80 µl	EUR 343.2

Breast Cancer Anti-Estrogen Resistance 3 (BCAR3) Antibody
20-abx324781	Abbexa	EUR 376.80 EUR 292.80	100 ug 50 ug

Recombinant Breast Cancer Anti-Estrogen Resistance 3 (BCAR3)
4-RPG768Hu01	Cloud-Clone	EUR 601.69 EUR 284.40 EUR 1926.34 EUR 722.11 EUR 1324.22 EUR 477.60 EUR 4635.84	100 ug 10ug 1 mg 200 ug 500 ug 50ug 5 mg
Description: Recombinant Human Breast Cancer Anti-Estrogen Resistance 3 expressed in: E.coli

9998 SCREW CAP 415/15
9998-15	CORNING	288/pk	EUR 237.6
Description: General Apparatus; Stoppers

Pesticide Mix 3 Containing 15 Compounds in Acetonitrile
SPXPR-3	Scientific Laboratory Supplies	1ML	EUR 214.32

Breast Cancer and 8 types of tumor (middle advanced stage)tissue array
BR20838a	TissueArray	each	EUR 474
Description: Breast Cancer and 8 types of tumor (middle advanced stage)tissue array, including pathology grade, TNM/stage with IHC Her-2 results, 118 cases/208 cores (core size 1.5mm), replacing BR20838

Breast Cancer Metastasis Suppressor 1 Protein
20-abx263402	Abbexa	EUR 1930.80 EUR 393.60 EUR 276.00	100 ug 10 ug 2 µg

Autobioluminescent Human Breast Cancer Cells (MCF7)
ASE-5903	Applied StemCell	1 ml	EUR 2490
Description: 6 month

Autobioluminescent Human Breast Cancer Cells (T47D)
ASE-5904	Applied StemCell	1 ml	EUR 2490
Description: 6 month

Human Breast Cancer Signaling Primer Library
HBRCA-I	Real Time Primers	1 set	EUR 657.6

Breast Cancer Anti-Estrogen Resistance 1
PR27245	Neuromics	2 ug	EUR 229.2

Anti-Breast Cancer Resistance Protein antibody
STJ16100903	St John's Laboratory	1 mL	EUR 573.6

Anti-Breast Cancer Resistance Protein antibody
STJ16100916	St John's Laboratory	1 mL	EUR 573.6

anti-Breast cancer suppressor candidate 1
YF-PA24096	Abfrontier	50 ul	EUR 400.8
Description: Mouse polyclonal to Breast cancer suppressor candidate 1

anti-Breast cancer suppressor candidate 1
YF-PA12974	Abfrontier	50 ul	EUR 435.6
Description: Mouse polyclonal to Breast cancer suppressor candidate 1

anti-Breast cancer suppressor candidate 1
YF-PA12975	Abfrontier	50 ug	EUR 435.6
Description: Mouse polyclonal to Breast cancer suppressor candidate 1

Multiple types breast cancer tissue array
BR1003a	TissueArray	each	EUR 306
Description: Multiple types breast cancer tissue array, including pathology grade, TNM and clinical stage, 47 cases/101 cores, replacing BR1003

Late stage breast cancer tissue array
BR1922	TissueArray	each	EUR 546
Description: Late stage breast cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases/192 cores

Poorly differentiated breast cancer tissue array
BR351a	TissueArray	each	EUR 66
Description: Poorly differentiated breast cancer tissue array, including TNM, clinical stage and pathology grade, 35 cases/35 cores, replacing BR351

Breast cancer and normal tissue array
BR485	TissueArray	each	EUR 414
Description: Breast cancer and normal tissue array, including TNM and pathology grade, 2 serial sections, 48 cases/96 cores

High-density breast cancer tissue array
BR6161	TissueArray	each	EUR 954
Description: High-density breast cancer tissue array, with stage, grade and normal breast tissue, 322 cases/616 cores

Breast cancer and normal tissue array
BR8014	TissueArray	each	EUR 306
Description: Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases/80 cores, replaced by BR8015

Breast tumor tissue array (3 of 5)
BR20834a	TissueArray	each	EUR 546
Description: Breast tumor tissue array (3 of 5), including pathology grade, TNM and clinical stage, 208 cases/208 cores, replacing BR20834

Breast Tumor Tissue Array - 16 cases of breast cancer, each in duplicates, paired with adjacent normal tissues
Z7020007	Biochain	5 slides	EUR 1657.2
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool.

Breast cancer with matched metastatic carcinoma or breast tissue array
BRM961a	TissueArray	each	EUR 384
Description: Breast cancer with matched metastatic carcinoma or breast tissue array, including pathology grade, TNM, clinical stage and IHC marker (ER, PR and Her-2), 49 cases/96 cores

Human Cancer Antigen CA15-3 Protein
abx060965-50kU	Abbexa	50 kU	EUR 3150

Breast Tumor Kinase Blocking Peptide
AF4768-BP	Affbiotech	1mg	EUR 234

Breast Tumor Kinase antibody (Tyr447)
70R-33384	Fitzgerald	100 ug	EUR 392.4
Description: Rabbit polyclonal Breast Tumor Kinase antibody (Tyr447)

Human Tumor Tissue: Breast cDNA
HT05-090	Alpha Diagnostics	10 rxn	EUR 498

Anti-Rabbit Whole Serum | GWS-15
GWS-15	Immunology Consultants Laboratory	1.0 mL	EUR 130
Description: Anti-Rabbit Whole Serum | GWS-15 | Immunology Consultants Laboratory Host: Goat Format: Whole Serum Product Type: Primary Antibody Antibody Clonality: Polyclonal

Liquid Wicks, Size 15, 200 /pk
W-15	MiTeGen	200 WICKS	EUR 22
Description: Liquid Wicks, Size 15, 200 /pk

Cancer Antigen 125 Antigen (Human Adenocarcinoma)
VAng-Cr3868-10kU	Creative Biolabs	10 kU	EUR 505.2
Description: Cancer Antigen 125 Antigen, Host/Source: Human Adenocarcinoma. The purity is detected by salt extraction and chromatography.

Cancer Antigen 125 Antigen (Ascites Fluid)
VAng-Cr3870-10kU	Creative Biolabs	10 kU	EUR 1132.8
Description: Cancer Antigen 125 Antigen, Host/Source: Ascites Fluid. The purity is ≥ 95% by SDS-PAGE.

Direct alteration of extracellular cues through in situ matrix softening reversed YAP exercise and the epigenetic program. Our findings recommend that epigenetic reprogramming of the mechanophysical properties of the extracellular microenvironment of stable tumours might symbolize a therapeutic technique for the inhibition of most cancers development.